IN
₹66.50
+0.04(+0.06%)
INDOUS₹66.50+0.06%
Value & Investment Index
VIIVII Detail
90 days · zone the stock traded inMultiples vs Peers
Quality Scores
Versus Its Own History
P/E · P/B percentile bandsScenario analysis
stated assumptions, shown workingsINDOUS valuation summary
Indo Us Biotech Limited trades at 12.7 times trailing earnings. Return on equity is 15.3% and return on capital employed is 14.5%. That P/E equals an earnings yield of 7.9%. The median P/E across 51 listed Agricultural Inputs companies is 15.7, so Indo Us Biotech Limited trades at a 94% premium to that median.
| P/E | 12.7 |
|---|---|
| ROE | 15.3% |
| ROCE | 14.5% |